Prescription for success

The intense nature of competing internationally in the pharmaceutical industry has driven drug companies to significantly shorten their drug development processes. Despite this, and the fact that these companies spend billions each year on projects and professional staff salaries, many pharmaceutical companies often neglect the one element that will enable them to most effectively and efficiently accomplish their project goals and organizational objectives--the element of using project management. This article details the impact of using project management to develop pharmaceutical products. In doing so, it examines how three companies--the project-driven Wyeth (Collegeville, PA, USA), the matrix-structured Sanofi Pasteur (Paris, France), and the principle-based TargeGen (San Diego, CA, USA)--use project management to develop new products. In doing so, it describes the emerging pharmaceutical industry trend of working in corporate alliances to develop products and explains the challenges of managing these all
registered user content locked

Log in or join PMI to gain access

or Account Registration

Advertisement

Advertisement

Related Content

Advertisement

Publishing or acceptance of an advertisement is neither a guarantee nor endorsement of the advertiser's product or service. View advertising policy.